Anti-Interleukin-5 Antibody

· National Institute of Allergy and Infectious Diseases (NIAID)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Anti-Interleukin-5 Antibody, covering 2008-03-04 to 2008-03-04. Get the full timeline:

Most recent: Clinical Trial Update: Anti-Interleukin-5 Antibody to Treat Hypereosinophilic Syndrome [Phase 2]